Navigation Links
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
Date:10/19/2013

Researchers, led by University of Washington (UW) physicist Jens Gundlach, have developed a nanopore sequencing technology that is capable of reading the sequence of a single DNA molecule. In this system, the DNA is pulled through a nanopore while an ion current through the pore electronically reads the DNA's sequence. The nanopore is an engineered protein developed specifically for DNA sequencing by Gundlach's team in collaboration with Michael Niederweis, a microbiologist at the University of Alabama-Birmingham (UAB). This technology has led to a patent-licensing deal between UW and Illumina, Inc.

The licensing deal gives San Diego-based Illumina, Inc., developer of integrated systems for genetic variation analysis, exclusive worldwide rights to develop and market the nanopore DNA sequencing technology that is based on the engineered pore.

"Many companies and universities are looking at nanopore technology as one way to realize that potential, but the technology developed by Drs. Gundlach and Niederweis is among the most promising," said Christian Henry, Senior Vice President and General Manager of Illumina's Genomics Solutions business.

The nanopore was created by genetically engineering a protein pore from a mycobacterium smegmatis. The pore has an opening 1 billionth of a meter in size, just large enough for a single DNA strand to pass through, but needed to be modified to become useful for this sequencing technology.

Last year Gundlach's team published a study in Nature Biotechnology that found the combination of a genetically altered M. smegmatis pore and DNA polymerase could be used to directly determine DNA sequences using just single DNA molecules. The polymerase serves as a molecular motor that moves a DNA strand through the pore one nucleotide at a time. Their study reported a successful demonstration of this new technique using six different strands of DNA. The results corresponded to the already known DNA sequence of the strands, which had readable regions 42 to 53 nucleotides long.

While mycobacterial nanopores were first studied as potential chinks in the armor of the tuberculosis bacteria, they are now part of efforts to make genetic sequencing faster and cheaper. Gundlach believes this may lead to readily available personalized medicine, potentially revealing predispositions for a variety of illnesses, such as cancer, diabetes and addiction.

Sequencing reveals genetic variations, which partly determine each person's risk for many diseases, as well as which drugs will work best for each individual. Cancer centers are already sequencing tumors in search of variations that make some resistant to chemotherapy. And global sequencing studies seek to find the genetic contributors to a variety of conditions from autism to diabetes.

"The nanopore technique also can be used to identify subtle DNA modifications that happen over the lifetime of an individual," said Gundlach. Such modifications, referred to as epigenetic DNA modifications, may take place as chemical reactions on the DNA within cells -- and tell the cells how to interpret their DNA. While essential for proper cellular functioning, epigenetic modifications can also be the underlying causes of various undesired conditions.

"Epigenetic modifications are important for things like cancer," Gundlach said, "and being able to provide DNA sequencing that can directly identify epigenetic changes is one of the charms of the nanopore sequencing method."


'/>"/>

Contact: Clare LaFond
clarela@uw.edu
206-616-9540
UW Center for Commercialization (UW C4C)
Source:Eurekalert

Related biology technology :

1. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
2. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
3. Sangui and SastoMed Complement Licensing Agreement in View of Increasing Sales Success
4. LLSs Lead Therapy Acceleration Program in MDS Gets Boost from Major Industry Licensing Agreement
5. Robert Haynes To Lead Licensing As VR Laboratories Senior Vice President Product Introduction And Licensing
6. Infinata’s BioPharm Insight Releases Licensing League Tables Report for 4Q12 and YE12
7. Stemedica Enters into Stem Cell Licensing Agreement with Kalbe Farma
8. UM Ventures and SilcsBio, LLC Announce Licensing Agreement
9. Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
10. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
11. Enteris BioPharma and Nordic BioSciences KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris Proprietary Oral Drug Delivery and Manufacturing Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... quality, regulatory and technical consulting, provides a free webinar on Performing ... July 13, 2016 at 12pm CT at no charge. , Incomplete investigations are ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... Cell Applications, Inc. and StemoniX announced ... up to one billion human induced pluripotent stem ... These high-quality, consistent stem cells enable researchers to ... more time doing meaningful, relevant research. This achievement ... process that produces affordable, reliable HiPSC for life ...
(Date:6/22/2016)... YORK , June 22, 2016  According ... growing next generation sequencing (NGS) market include significant ... of smaller sequencers.  More accessible and affordable sequencers, ... to growing demand for consumables including sample prep ... The Market for Sample Preparation for Next Generation ...
Breaking Biology Technology:
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
Breaking Biology News(10 mins):